Mostrar el registro sencillo del ítem
dc.contributor.author
Datta, K.
dc.contributor.author
Rhee, P.
dc.contributor.author
Byrnes III, E.
dc.contributor.author
Garcia, Guillermo Manuel
dc.contributor.author
Perlin, D. S.
dc.contributor.author
Staab, J. F.
dc.contributor.author
Marr, K. A.
dc.date.available
2016-07-14T20:52:00Z
dc.date.issued
2013-06
dc.identifier.citation
Datta, K.; Rhee, P.; Byrnes III, E.; Garcia, Guillermo Manuel; Perlin, D. S.; et al.; Isavuconazole activity against emerging fungal pathogens with reduced azole-susceptibility: Aspergillus lentulus, Neosartorya udagawae and Cryptococcus gattii; American Society For Microbiology; Journal of Clinical Microbiology; 51; 9; 6-2013; 3090-3093
dc.identifier.issn
0095-1137
dc.identifier.uri
http://hdl.handle.net/11336/6512
dc.description.abstract
Isavuconazole is an extended-spectrum triazole with in vitro activity against a wide variety of fungal pathogens. Clinical isolates of molds Aspergillus lentulus and Neosartorya udagawae and yeast Cryptococcus gattii VGII (implicated in the outbreak in the Pacific Northwest, North America) exhibit reduced susceptibilities to several azoles but higher susceptibilities to isavuconazole.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
American Society For Microbiology
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
Isovuconazol
dc.subject
Susceptibility
dc.subject
Aspergillus Lentulus
dc.subject
Cryptococcus Gatti
dc.subject.classification
Enfermedades Infecciosas
dc.subject.classification
Ciencias de la Salud
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Isavuconazole activity against emerging fungal pathogens with reduced azole-susceptibility: Aspergillus lentulus, Neosartorya udagawae and Cryptococcus gattii
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2016-07-06T15:45:38Z
dc.journal.volume
51
dc.journal.number
9
dc.journal.pagination
3090-3093
dc.journal.pais
Estados Unidos
dc.journal.ciudad
Washington
dc.description.fil
Fil: Datta, K.. University Johns Hopkins; Estados Unidos
dc.description.fil
Fil: Rhee, P.. University Johns Hopkins; Estados Unidos
dc.description.fil
Fil: Byrnes III, E.. University Johns Hopkins; Estados Unidos
dc.description.fil
Fil: Garcia, Guillermo Manuel. Universidad Nacional del Litoral. Facultad de Bioquímica y Ciencias Biológicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Santa Fe; Argentina
dc.description.fil
Fil: Perlin, D. S.. University of Medicine and Dentistry of New Jersey. New Jersey Medical School. Public Health Research Institute Center; Estados Unidos
dc.description.fil
Fil: Staab, J. F.. University Johns Hopkins; Estados Unidos
dc.description.fil
Fil: Marr, K. A.. University Johns Hopkins; Estados Unidos
dc.journal.title
Journal of Clinical Microbiology
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1128/JCM.01190-13
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/10.1128/JCM.01190-13
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://jcm.asm.org/content/51/9/3090
Archivos asociados
Tamaño:
199.7Kb
Formato:
PDF